Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 2, 1996, Pages 855-865

  Lew, Robert ^a   Sabol, Karen E ^a   Chou, Cynthia ^a   Vosmer, Georgetta L ^a   Richards, Jerry ^a   Seiden, Lewis S ^a,b  

^a Dept Pharmacol Physiological Sci ^*  (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; COCAINE; DOPAMINE; DRUG DERIVATIVE; SEROTONIN; SEROTONIN RECEPTOR AFFECTING AGENT;

ANIMAL; ARTICLE; AUTORADIOGRAPHY; BRAIN; DRUG EFFECT; MALE; METABOLISM; RADIOASSAY; RAT; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; AUTORADIOGRAPHY; BRAIN; COCAINE; DOPAMINE; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; TIME FACTORS;

EID: 0030087725     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. ANDERSON, G. M., BRAUN, G., BRAUN, U., NICHOLS, D. E. AND SHULGIN, A. T.: Absolute configuration and psychomimetic activity. NIDA Res. Monogr. 22: 8-15, 1978
2. APPEL, N. M., CONTRERA, J. F. AND DE, S. E.: Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: Evidence from immunocytochemical studies. J. Pharmacol. Exp. Ther. 249: 928-943, 1989.
3. APPEL, N. M., MITCHELL, W. M., CONTRERA, J. F. AND DE, S. E.: Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography. Synapse 6: 33-44, 1990.
4. AXT, K. J., MAMOUNAS, L. A. & MOLLIVER, M. E.: Regeneration of 5-HT projections to neocortex: magnitude of p-chloramphetamine-induced denervation innervation influences reinnervation. Soc. Neurosci. Abst. 18: 629, 1992a.
5. AXT, K. J., MULLEN, C. A. & MOLLIVER, M. E.: Cytopathologic features indicative of 5-hydroxytryptamine axon degeneration are observed in rat brain after administration of d- and 1-methylenedioxyamphetamine. Ann. N. Y. Acad. Sci. 648: 244-247, 1992b.
6. AZMITIA, E. C. AND SEGAL, M.: An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neur. 179: 641-688, 1978.
7. BATTAGLIA, G., BROOKS, B. P., KULSAKDINUN, C AND DE, S. E.: Pharmacologic profile of MDMA (3,4-metnylenedioxymethamphetamine) at various brain recognition sites. Eur. J. Pharmacol. 149: 159-163, 1988a.
8. BATTAGLIA, G., SHARKEY, J., KUHAR, M. J AND DESOUZA, E. B.: Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): Assessment using quantitative autoradiography. Synapse 8: 249-260, 1991.
9. BATTAGLIA, G., YEH, S. Y. AND DE, S. E.: MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons. Pharmaco. Biochem Behav. 29: 269-274, 1988b.
10. BATTAGLIA, G., YEH, S. Y., O'HEARN, E., MOLLIVER, M. E , KUHAR, M. J. AND DE, S. E.: 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J. Pharmacol. Exp. Ther. 242: 911-916, 1987.
11. BEARDSLEY, P. M., BALSTER, R. L. AND HARRIS, L. S.: Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug Alcohol Depend. 18: 149-157, 1986.
12. BJORKLUND, A., NOBIN, A AND STENEVI, U.: Regeneration of central serotonin neurons after axonal degeneration induced by 5,6-dibydroxytryptamine. Brain Res. 50: 214-220, 1973.
13. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12: 27-36, 1992.
14. BOST, R. O.: 3,4-Methylenedioxymethamphetamine (MDMA) and other amphetamine derivatives. J. Forensic Sci. 33: 576-587, 1988.
15. BRAUN, U., SHULGIN, A. T. AND BRAUN, G.: Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine). J. Pharmaceut Sci. 69: 192-195, 1980.
16. COMMINS, D. L., VOSMER, G., VIRUS, R. M., WOOLVERTON, W. L., SCHUSTER, C. R. AND SEIDEN, L. S.: Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. J. Pharmacol. Exp. Therap. 241: 338-345, 1987
17. DESOUZA, E. AND BATTAGLIA, G.: Effects of MDMA and MDA on brain serotonin neurons: evidence from neurochemical and autoradiographic studies. Nida Res. Monog. Ser. 94: 196-222, 1989.
18. GREER, G. AND STRASSMAN, R. J.: Information on "Ecstasy," Am. J. Psychiatr. 142: 1391, 1985.
19. HEFFNER, T. G., HARTMAN, J. A. AND SEIDEN, L. S.: A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 13: 453-456, 1980.
20. INSEL, T. R., BATTAGLIA, G., JOHANNESSEN, J. N., MARRA, S. AND DE, S. E. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. J. Pharmacol. Exp. Therap. 249: 713-720, 1989.
21. JACOBS, B. L. AND AZMITA, E. C.: Structure and function of the brain serotonin system. Physiol. Rev. 72: 165-229, 1992.
22. KLEVEN, M. S , WOOLVERTON, W. L. AND SEIDEN, L S.: Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys. Brain Res. 488: 121-125, 1989.
23. KOSOFSKY, B. E. AND MOLLIVER, M. E The serotoninergic innervation of cerebral cortex Different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse 1: 153-168, 1987.
24. LAMB, R. J. AND GRIFFITHS, R. R.: Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon. Psychopharmacology 91: 268-272, 1987.
25. Li, A A., MAREK, G. J., VOSMER, G. AND SEIDEN, L. S.: Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats. Pharmacol. Biochem. Behav. 33: 641-648, 1989.
26. MAMOUNAS, L. A. AND MOLLIVER, M E.: Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA). Exp Neurol. 102: 23-36, 1988.
27. MAMOUNAS, L. A., MULLEN, C. A., O'HEARN, E. AND MOLLIVER, M. E.: Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J. Comp. Neurol. 314: 558-586, 1991.
28. MOLLIVER, M. E.: Serotonergic neuronal systems: what their anatomic organization tells us about function. J. Clin. Psychopharmcol. 7(6 Suppl): 3S-23S, 1987.
29. MOLLIVER, M. E., BERGER, U. V., MAMOUNAS, L. A., MOLLIVER, D. C., O'HEARN, E. AND WILSON, M A.: Neurotoxicity of MDMA and related compounds: anatomic studies. Ann. N.Y. Acad. Sci. 600: 649-661, 1990.
30. MOLLIVER, M. E., MAMOUNAS, L. A. AND WILSON, M. A.: Effects of neurotoxic amphetamines on serotonergic neurons: immunocytochemical studies. Nida Res. Monogr. Series 94: 270-305, 1989.
31. O'HEARN, E., BATTAGLIA, G., DE, S E., KUHAR, M J. AND MOLLIVER, M. E.: Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 8: 2788-2803, 1988.
32. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, New York, 1986.
33. PEROUTKA, S. J., NEWMAN, H. AND HARRIS, H.: Subjective effects of 3,4-methylenedioxymethamphetamine m recreational users Neurpsychopharmacology 1: 273-277, 1988.
34. RICAURTE, G. A., DELANNEY, L. E., IRWIN, I. AND LANGSTON, J. W.: Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res. 446: 165-168, 1988a.
35. RICAURTE, G. A., FORNO, L. S., WILSON, M. A., DELANNEY, L. E., IRWIN, I., MOLLIVER, M. E. AND LANGSTON, J. W.: (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA 260: 51-55, 1988b.
36. RICAURTE, G. A., MARKOWSKA, A. L., WENK, G. L , HATZIDIMITRIOU, G , WLOS, J. AND OLTON, D. S.: 3,4-Methylenedioxymethamphetamine, serotonin and memory [published erratum appears in J Pharmacol Exp Ther 1994 Jan: 268(1):529]. J. Pharmacol. Exp. Therap. 266: 1097-1105, 1993.
37. RICAURTE, G. A., MARTELLO, A. L , KATZ, J. L. AND MARTELLO, M B.: Lasting effects of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J. Pharmacol. Exp. Therap. 261: 616-622, 1992.
38. SABOL, K. E., LEW, R., RICHARDS, J. B., VOSMER, G. L. AND SEIDEN, L. S.: Methlenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part 1: Synaptosomal uptake and tissue concentrations. J. Pharmacol. Exp. Ther. 276: 846-854, 1996.
39. SANDERS-BUSH, E. AND STERANKA, L. R.: Immediate and long-term effects of p-chloroamphetamine on brain amines. Ann. N.Y. Acad. Sci 305: 208-221, 1978.
40. SCANZELLO, C. R., HATZIDIMITRIOU, G., MARTELLO, A. L., KATZ, J. L. AND RICAURTE, G. A.: Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats. J. Pharmacol. Exp. Therap. 264: 1484-1491, 1993.
41. SHARKEY, J., MCBEAN, D. E. AND KELLY, P. A.: Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy") Psychopharmacology 105: 113-118, 1991.
42. SHULGIN, A. T. AND JACOB, P.: Potential misrepresentation of 3,4-methylenedioxyamphetamine (MDA). A toxicological warning. J Anal. Toxicol. 6: 71-75, 1982.
43. SLIKKER, W. J., HOLSON, R. R., ALI, S. F., KOLTA, M. G., PAULE, M. G., SCALLET, A. C., MCMILLAN, D. E., BAILEY, J. R., HONG, J. S AND SCALZO, F. M.: Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. Neurotoxicology 10: 529-542, 1989.
44. TORK, I.: Raphe nuclei and serotonin containing systems. In The Rat Nervous System: Hindbrain and Spinal Cord ed. by G. Paxinos, pp. 43-78, Academic Press, New York, 1985.
45. United States Department of Justice, Drug Enforcement Administration: Statement in the Matter of MDMA Scheduling (Docket no. 84-48), Washington, D.C., 1985.
46. WIKLUND, L., BJORKLUND, A. AND NOBIN, A : Regeneration of serotonin neurons in the rat brain after 5,6-dihydroxytryptamine induced axotomy. Ann. N.Y. Acad. Sci. 305: 370-384, 1978.
47. WILSON, M. A., RICAURTE, G. A. AND MOLLIVER, M. E : Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine. Neuroscience 28: 121-137, 1989.